Related Experiment Video
Updated: Mar 8, 2026

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Effects of sevoflurane on cardiopulmonary function in patients undergoing coronary artery bypass
1Department of Anesthesia, The East Area of the Central Hospital of Xinxiang, Xinxiang, PR China.
Insights
Sevoflurane may stabilize cardiopulmonary function and reduce myocardial injury in coronary artery bypass grafting (CABG) patients. While not improving left ventricular ejection fraction (LVEF), it showed benefits in oxygenation and reduced cardiac enzyme release.
Area of Science:
- Anesthesiology and Critical Care Medicine
- Cardiovascular Surgery
- Respiratory Physiology
Background:
- Investigated the impact of sevoflurane on cardiopulmonary function during Coronary Artery Bypass Grafting (CABG).
- Compared sevoflurane anesthesia with standard care in 60 patients with Coronary Heart Disease (CHD).
Discussion:
- Sevoflurane group showed lower mean arterial pressure (MAP), heart rate (HR), and creatine kinase isoenzyme (CK-MB) levels post-operation.
- While left ventricular ejection fraction (LVEF) was not improved, sevoflurane administration positively impacted respiratory parameters.
- Improved oxygenation index (PaO2/FiO2) and reduced alveolar-arterial blood oxygen partial pressure (PA-aO2) were observed in the sevoflurane group.
Key Insights:
- Sevoflurane administration during CABG may mitigate myocardial injury, evidenced by lower CK-MB levels.
- Enhanced respiratory function, including higher tidal volume (Vt) and vital capacity (Vc), was noted with sevoflurane.
- Sevoflurane contributed to better oxygenation (PaO2/FiO2) and reduced physiological dead space (PA-aO2).
Outlook:
- Further research could explore optimal sevoflurane dosing for cardiopulmonary stabilization in CABG.
- Investigating long-term cardiac outcomes and potential synergistic effects with other anesthetic agents is warranted.
- Clinical trials focusing on sevoflurane's role in reducing perioperative myocardial infarction are recommended.
Abstract:
The objective of the current study was to investigate effects of sevoflurane on cardiopulmonary function in patients undergoing coronary artery bypass grafting (CABG). In this study, 60 cases of patients with coronary heart disease (CHD) were selected and randomly divided into the sevoflurane group (group S) and the control group C (group C) with 30 cases in each group. The two groups received intravenous anesthesia. The patients of group C were only given oxygen mask and physiological saline to keep vein open; while the patients of group S were administered with 1% sevoflurane immediately after the beginning of cardiopulmonary bypass (CPB) until the end of the treatment. The cardiopulmonary functions at 30 min before operation (T0), postoperative 2 h (T1), 6h (T2), 24h (T3) and 48 (T4) were observed. The mean arterial pressure (MAP) of the group S at T1, T2, T3 was lower than that of the group C, as were the heart rate (HR) and left ventricular ejection fraction (LVEF). The creatine kinase isoenzyme (CK-MB) during T1 to T4 in the group S was less than that of the group C, and there were significant differences between the two groups (P less than 0.05). The tidal volume (Vt), vital capacity (Vc) and oxygenation index (PaO2/FiO2) of the two groups during T1 and T2 were decreased, while respiratory frequency (RR) and alveolar-arterial blood oxygen partial pressure (PA-aO2) were increased and they began to decrease during T3 and T4. Vt and Vc of the group S were higher during T1 and T2 periods than those of the group C, while RR was lower than that of the group C; PaO2 / FiO2 during T1 to T4 period of group S was higher than that of group C, while PA-aO2 was significantly lower than that of the control group (P less than 0.05). In conclusion, although LVEF was not improved in the sevoflurane group, sevoflurane may contribute to stabilizing the cardiopulmonary function and preventing from myocardial injury.
More Related Videos
Related Concept Videos
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Cardiopulmonary Resuscitation IV: Pharmacological Management
Inhalational Anesthetics: Overview
General Anesthesia: Overview
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
Cardiopulmonary Resuscitation II: ACLS Airway Management
Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques

